T cell immunity ameliorates COVID-19 disease severity and provides post-exposure prophylaxis after peptide-vaccination, in Syrian hamsters

BACKGROUND: The emergence of novel SARS-CoV-2 variants that resist neutralizing antibodies drew the attention to cellular immunity and calls for the development of alternative vaccination strategies to combat the pandemic. Here, we have assessed the kinetics of T cell responses and protective effica...

Descripción completa

Detalles Bibliográficos
Autores principales: Somogyi, Eszter, Kremlitzka, Mariann, Csiszovszki, Zsolt, Molnár, Levente, Lőrincz, Orsolya, Tóth, József, de Waal, Leon, Pattijn, Sofie, Reineking, Wencke, Beineke, Andreas, Tőke, Enikő R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902696/
https://www.ncbi.nlm.nih.gov/pubmed/36761759
http://dx.doi.org/10.3389/fimmu.2023.1111629

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902696/
https://www.ncbi.nlm.nih.gov/pubmed/36761759
http://dx.doi.org/10.3389/fimmu.2023.1111629

Ejemplares similares